Merck’s drug for diabetes-related eye disease shows promise in trial

Merck’s drug for diabetes-related eye disease shows promise in trial Merck MRK.N said on Thursday its injectable drug to treat a serious eye disease affecting diabetes patients met the main goal in a mid- to late-stage trial.

1 reportother

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage